1. Home
  2. INLX vs CRVO Comparison

INLX vs CRVO Comparison

Compare INLX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$6.70

Market Cap

30.4M

Sector

Technology

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.01

Market Cap

35.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
CRVO
Founded
1996
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4M
35.9M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
INLX
CRVO
Price
$6.70
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
1.7K
60.3K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,336.00
$4,006,510.00
Revenue This Year
$16.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$2.82
52 Week High
$14.57
$13.13

Technical Indicators

Market Signals
Indicator
INLX
CRVO
Relative Strength Index (RSI) 44.15 34.51
Support Level N/A $2.82
Resistance Level $7.87 $4.27
Average True Range (ATR) 0.28 0.25
MACD -0.04 -0.04
Stochastic Oscillator 29.22 16.08

Price Performance

Historical Comparison
INLX
CRVO

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: